The largest database of trusted experimental protocols

62 protocols using mitomycin c

1

Mitomycin C Sensitivity Assay for Huntington's Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphoblastoid cell lines from individuals with HD were obtained from EHDN (projects 0791 and 0803). Lines were cultured in RPMI-1640 GlutaMAX (Thermo Fisher Scientific) supplemented with 15% FBS and 1% penicillin–streptomycin and passaged three times per week. For the mitomycin C survival assays, cell lines (viability > 80%) were seeded in triplicate at 20,000 cells per well in 12-well plates, treated once with mitomycin C (0–150 nM, SelleckChem) and cultured for a further 7 days before viable cell counts were determined by trypan blue staining (Countess II, Thermo Fisher Scientific). Each experiment was independently repeated three times. Difference in means was tested using Student’s t-test (two-tailed). Data distribution was assumed to be normal, but this was not formally tested.
+ Open protocol
+ Expand
2

Stimulating CD44v6 CAR-T Cells with Mitomycin-C

Check if the same lab product or an alternative is used in the 5 most similar protocols
MV4-11 cells treated with 10 μg/ml Mitomycin-C (Selleck, S8146) for 2 h were used to stimulate CD44v6 CAR-T cells pretreated with Dec 0.1 μM or Aza 1 μM. The E: T ratio and stimulation time were the same in each round. A round of stimulation was followed by staining CAR-T cells with trypan-blue and counting them under the microscope. CAR-T cells were isolated from MV4-11 cells that had been lysed. All CAR-T cells obtained in the last round were used as the initial cells for the next round of stimulation. The proliferation fold change is the ratio of cell counts after different rounds of stimulation compared to cell counts before stimulation.
+ Open protocol
+ Expand
3

Scratch Assay and Matrigel Invasion Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The experiments were conducted as described in previous research.43 (link) Briefly, the cells were evenly planted on a six-well plate and grown into a confluent monolayer. Subsequently, a scratch was made and marked on the underside of the plate to ensure that the images were observed at identical places at 0 and 48 h. The migrated areas were calculated using Image-Pro Plus 6.0 software.
The Transwell chamber was precoated with 50 μL matrix gel (BD Biosciences, San Jose, CA). A total of 2 × 105 cells were then inoculated into the upper chamber. The invading cells were stained after 48 h and counted for the Matrigel invasion assay. In the above experiments, cell proliferation was inhibited using mitomycin C (Selleckchem, USA).
+ Open protocol
+ Expand
4

Transwell Assay for Migration and Invasion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transwell assays were performed by using transwell chambers (8 μm pore size, Corning) to examine the migration and invasion of ESCC cells as previously described (30 (link)). Briefly, tumor cells were pretreated with 10 μg/mL mitomycin C (Selleck, Shanghai, China) for 2 h. For the migration experiment, Approximately 5 × 104 cells were placed into the upper chamber with 200 μl serum-free DMEM medium, The lower compartment filled with DMEM medium supplement with 20% FBS was used as the chemoattractant. For the invasion assay, the upper surface of chamber membrane were coated with 50 μL Matrigel (Cat. #354234, BD Biosciences, CA) to form a matrix barrier, and then 1 × 105 tumor cells were added to the upper chamber. After incubation for 24 h in a humidified incubator containing 5% CO2 at 37°C, the cells on the lower surface of the chamber membrane were fixed with 4.0% paraformaldehyde prior to 0.1% crystal violet staining. Pictures were then captured under a light microscope at 10 × and the mean number of migrated or invaded cells were counted in five random fields.
+ Open protocol
+ Expand
5

Culturing Human Liver Cancer and Kidney Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human liver cancer cell line HCCLM3 was obtained from the Liver Cancer Institute, Zhongshan Hospital, Fudan University (Shanghai, China). The human liver cancer cell line Hep3B and the human embryonic kidney cell line HEK293T were obtained from American Type Culture Collection (ATCC). All cells were cultured in Dulbecco's Modified Eagle's medium (DMEM) (Corning) supplemented with 10% fetal bovine serum (FBS) (VISTECH), 100 U/ml of penicillin and 100 µg/ml of streptomycin (P/S) (Hyclone) in a humidified incubator at 37°C with 5% CO2. Commercially available antibodies used in this study included anti-Rictor (Bethyl, A500-002A), anti-ABLIM1 (Abcam, ab222824 and Proteintech, 15129-1-AP), anti-MKL1 (Proteintech, 21166-1-AP), anti-phosphoserine (Abcam, ab9332), anti-phospho-AKT (Ser473) (Cell Signaling Technology, 4060T), anti-AKT (Cell Signaling Technology, 4685S), anti-Flag (Sigma, F3165-2MG), anti-β-Actin (Santa Cruz, sc-69879) and anti-GAPDH (Santa Cruz, sc-47724), anti-c-Fos (Cell Signaling Technology, 2250S), anti-Arp3 (Proteintech, 13822-1-AP). Mitomycin C was from Selleck (S8146).
+ Open protocol
+ Expand
6

Evaluating T Cell Activation in Mixed Lymphocyte Reaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mixed lymphocyte reaction (MLR) was utilized to determine T cell activation induced by HS636 and BR102. For HS636, monocytes were isolated from PBMCs using CD14 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and grown in Mo-DC differentiation medium (Miltenyi Biotec) and Mo-DC maturation medium (Miltenyi Biotec) to generate immature dendritic cells (DCs). Human CD4 + T cells isolated from a different PBMC donor were co-cultured with the DCs in a 96-well plate, and indicated antibodies were added. Alternatively, DCs were stimulated with Mitomycin C (50 μg/mL, Selleck, Houston, TX, USA) at 37 °C for 30 min. Subsequently, DCs (5 × 103 cells) were co-cultured with allogeneic PBMCs (1 × 105) in the presence of BR102 or HS636. After 3 days of culture, IFN-γ or IL-2 secretion in cell supernatants were analyzed by ELISA.
+ Open protocol
+ Expand
7

Maintenance of Mouse Embryonic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
R1/E (purchased from Cell Bank of Chinese Academy of Sciences) and TC1 (a gift from J. Kang)28 (link) cells were maintained in Dulbecco’s Modified Eagle Medium (Basal Media) supplemented with 15% fetal bovine serum (Gibco), 1 × nonessential amino acids (Gibco), 1 × GlutaMAX (Gibco), 1 × sodium pyruvate (Gibco), 0.1 mm β-mercaptoethanol (Sigma), 1000 U mL−1 leukemia inhibitory factor (LIF) (Millipore), 100 U mL−1 penicillin, and 100 µg mL−1 streptomycin on mitomycin C (Selleck) inactivated mouse embryonic fibroblast feeder cells under 5% CO2 at 37 °C. ESCs were passaged every other day using 0.25% Trypsin at a split ratio of 1:5.
+ Open protocol
+ Expand
8

Cell migration and invasion assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transwell migration and invasion assays were undertaken to evaluate cell migration and invasion, respectively. Briefly, 3 × 104 cells resuspended in serum-free medium added with 5 µg/ml mitomycin C (Selleck, Houston, TX, USA) to block cell proliferation were placed into the upper chamber of transwell filter inserts (8-μm pore size, Corning, NY, USA) with or without precoated Matrigel (Corning). Complete medium added with 10% FBS was loaded into the lower chambers. After culture for another 36 h, the cells remaining on the upper chamber were removed. The cells migrating or invading into the bottom side of the inserts were fixed, stained, and quantified under a microscope by counting at least five random high-power fields.
+ Open protocol
+ Expand
9

Allogeneic PBMC Activation by DCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dendritic cells (AllCells) were treated with 50 µg/mL Mitomycin C (Selleck) at 37°C for 30 min and then plated onto a 96-well plate at 5×103 cells per well. Allogeneic PBMCs (AllCells) from different donors were added at a dendritic cell:PBMCs ratio of 1:20. Indicated mAbs were added at a concentration of 10 µg/mL immediately, and the cells were incubated at 37°C in 5% CO2 for 5 days. Interferon (IFN)γ secretion were evaluated in the supernatant by ELISA (R&D Systems).
+ Open protocol
+ Expand
10

Comprehensive Anticancer Compound Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CB-839, mitomycin C, cryptotanshinone, altretamine, GSK583, liproxstatin-1, spautin-1, PD-1/PD-L1 inhibitor 2, RVX-208, selinexor, ferrostatin-1, diacerein, LY2603618, and patupilone were purchased from Selleckchem (Houston, TX). Cisplatin, carboplatin and oxaliplatin were purchased from Sigma-Aldrich (St. Louis, MO). Olaprib, niraparib, veliparib were purchased from Cayman Chemical (Ann Arbor, MI). As2O3 was purchased from BioTang (Lexington, MA). C1–27 is a GSTO1 inhibitor previously identified and synthesized by our laboratory (5 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!